Biosimilars in Practice: Getting Practical A Q&A with Megan B. May, PharmD - Biosimilars Peer-to-Peer Megan B. May, PharmD, discusses biosimilars and their clinical applications. medpagetoday

At the end of a roundtable discussion last week, Florida's new surgeon general, Joseph Ladapo, MD, PhD, announced that COVID-19 vaccines are not recommended for "healthy children." This came as a complete shock to the scientific community, including pediatricians across the country.

Pfizer asks FDA to authorize 2nd Covid booster for people 65 and older If the FDA authorizes it, the additional shot would go to people who are among those with the highest risk of serious illness. NBC News

Pfizer and BioNTech are expected to seek U.S. authorization this week for a second Covid-19 vaccine booster for people 65 and older, according to a person familiar with the plans.

Omicron sub-variant makes up 23.1% of COVID variants in U.S. - CDC According to the CDC's data, the sub-variant now makes up 39% of total cases in regions including New Jersey, New York, Puerto Rico and Virgin Islands. In states such as Connecticut, Maine, Massachusetts, New Hampshire, Vermont and Rhode Island, the sub-variant now makes up about 38.6% of total cases. U.S. daily cases have started to decline in recent weeks after touching record levels in January, with the CDC dramatically easing its COVID-19 guidelines for masks, including in schools. YahooNews

...

Lasting depression and anxiety can follow severe case of Covid, study finds A large new study finds that mental health problems can be long-lasting, especially among patients who were bedridden for seven days or more. NBC News

Feelings of depression and anxiety can last nearly a year and a half after a serious bout of Covid-19, according to a study released Monday.

Medics and volunteers try to prop up Ukraine's health system When Russian bombs started falling on Kyiv, oncologist Nataliia Verovkina fled with her 10-year-old son. But once he was safe in Munich with his grandparents, she turned around and went back. Jennifer Rigby Reuters

...